New Dimensions in the Pharmacologic Treatment of Schizophrenia and Related Psychoses
- 1 May 1997
- journal article
- review article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 37 (5) , 363-378
- https://doi.org/10.1002/j.1552-4604.1997.tb04314.x
Abstract
During the past 5 years unprecedented advances have taken place in the psychopharmacology of schizophrenia and related psychoses. Clozapine and risperidone, two prototypic novel antipsychotic drugs, have had a significant impact on the treatment of psychotic disorders. Additionally, they have ushered in another generation of antipsychotic drugs with complex pharmacologic profiles, potentially enhanced efficacy, and more benign side‐effect profiles than previously associated with conventional antipsychotic medications. This review highlights these developments, implications for the management of psychotic disorders, and the use of novel antipsychotic drugs in specific clinical subgroups.Keywords
This publication has 79 references indexed in Scilit:
- P-22-9: The efficacy and safety of two fixed doses of ziprasidone in schizophreniaEuropean Neuropsychopharmacology, 1996
- Clozapine Eligibility Among State Hospital PatientsSchizophrenia Bulletin, 1996
- P-4-76 Risperidone in the treatment of first-episode patients with schizophreniform disorder: A double-blind multicenter studyEuropean Neuropsychopharmacology, 1995
- P-4-73 A randomized double-bind trial of risperidone versus clozapine for treatment-resistant chronic schizophreniaEuropean Neuropsychopharmacology, 1995
- Goals of Antihypertensive TherapyDrugs, 1995
- Effects of Tocopherol and Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1993
- A retrospective study on the long-term efficacy of clozapine in 96 schizophrenic and schizoaffective patients during a 13-year periodPsychopharmacology, 1989
- BENEFITS AND POTENTIAL HARM OF LOWERING HIGH BLOOD PRESSUREThe Lancet, 1987
- CLOZAPINE AND HALOPERIDOL IN A SINGLE‐BLIND CROSS‐OVER TRIAL: THERAPEUTIC AND BIOCHEMICAL ASPECTS IN THE TREATMENT OF SCHIZOPHRENIAActa Psychiatrica Scandinavica, 1974